Condition
Optic Atrophy, Autosomal Dominant
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Terminated1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07729982Recruiting
A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy
NCT06140329Terminated
Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
NCT01522638UnknownPrimary
Advanced Characterization of Autosomal Dominant Optic Atrophy
Showing all 3 trials